Per Persson, CEO of Acarix has been selected as Innovation Leader, to present at the LSI 2021 summit, CA, US next spring 

At LSI 2021, Mr. Persson will share the story of Acarix and provide timely updates to an audience of medtech investors, strategics, and industry insiders.

Objective: Provide a much needed in-person investment/networking event focused on medtech innovation

When: February 17-19, 2021

Where: The Ritz-Carlton, Dana Point, CA

Life science medtech-summit, CA, US 2021

About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.